FDA NDC Directory · JSON-LD · Markdown

Bivalirudin

NDC 16729-275 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namebivalirudin
Labeler / ManufacturerAccord Healthcare, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA206551
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsBIVALIRUDIN (250 mg/5mL)
Marketing started20181107
Package count1

External sources

Source: openFDA. Public-domain (CC0).